Bifogade filer
PDF
Beskrivning
| Land | Finland |
|---|---|
| Lista | Spotlight |
| Sektor | Handel & varor |
| Industri | Detaljhandel |
Eevia Health Plc ("Eevia" or "The Company") announces adjustments to the planned dates for the release of its Interim Report for Q1-2025 from Sunday, May 18, 2025 to Tuesday, May 20, 2025. Furthermore, the publication if its statutory financial statements for 2023 is moved to June 10, 2025. Finally, the Annual General Meeting (AGM) of Shareholders will be held on June 27, 2025.
For immediate release
Seinäjoki, Finland 16.5.2025
Due to multiple practical reasons, Eevia is adjusting its financial calendar, and is announcing the following:
- The publication of the Interim Report for Q1-2025 will be changed from May 18 to May 20, 2025, to not have the publication on a Sunday and to allow for Board approval just before the release.
- Eevia will publish its statutory financial statements and the auditor's report on June 10th, 2025.
- Eevia will hold its Annual General Meeting of the Shareholders (AGM) on Friday, June 27, 2025. The notice for the AGM will be published on June 10, 2025.
For further information, please contact:
Stein Ulve, CEO, Eevia Health Plc
Email: stein.ulve@eeviahealth.com or investor@eeviahealth.com
Telephone: +358 400 22 5967
INFORMATION ABOUT EEVIA HEALTH PLC
Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally, and these global brands utilize the ingredients in their consumer product formulas.
Eevia Health manufactures 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such as bilberry, lingonberry, chaga mushroom, and pine bark, are wild harvested sustainably.
Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. In June 2021, Eevia listed its shares on the Spotlight Stock Market in Sweden (Ticker EEVIA).
To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn@EeviaHealth.